Carlyle-backed life sciences investor launches $1.5bn clinical trials fund
Abingworth, a UK-based life sciences investor backed by Carlyle, is raising up to $1.5bn for clinical trials and royalty partnerships ...
Friday, December 13, 2024
Tag: 1.5bn
NZ Super trends up with almost $1.5bn of new mandates Investment News
Jo Townsend: NZ Superannuation Fund chief The NZ Superannuation Fund (NZS) has made half-a-dozen fresh investments over the previous few ...
Stay informed with News Wave - your reliable source for breaking news, insightful analysis, and engaging stories all in a summarized format.